Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME
Status:
Unknown status
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate if combination of intravitreal ranibizumab with
micropulse laser shows non inferiority compared to intravitreal ranibizumab only in diabetic
macular edema.